Eli Lilly's (LLY) Retatrutide demonstrated significant reductions in A1C and weight in first phase 3 trial for treatment of Type 2 Diabetes
Every headline is on the live feed 20 minutes before this site.
3M (MMM) acquires Madison Fire & Rescue and combines with Scott safety deal valued at USD 1.95bln; to receive USD 700mln cash proceeds upon closing
Russian Energy Ministry says fuel export ban may be introduced preventively in case of high prices
Eli Lilly's (LLY) Retatrutide demonstrated significant reductions in A1C and weight in first phase 3 trial for treatment of Type 2 Diabetes
Accenture (ACN) Q2 2026 (USD): EPS 2.93 (exp. 2.85), Revenue 18bln (exp. 17.84bln)
Newsquawk Daily US Opening News - 19th March 2026
On the Newsquawk feed at , 20 minutes before this page.
- Retatrutide lowered A1C by an average of 1.7-2.0% at 40 weeks.
- Participants showed weight loss of up to 16.8%.
Context
Eli Lilly's successful phase 3 trial results for Retatrutide highlight its potential as a competitive treatment for Type 2 Diabetes, with significant improvements in key health metrics like A1C and weight loss. This could enhance Eli Lilly's market positioning within the pharmaceuticals sector, potentially driving interest from investors and impacting earnings forecasts positively, especially in light of the growing diabetes treatment market.
Related headlines
- US BROKER MOVES: CPRI upgrade at Raymond James; WDAY downgraded at KeyBanc1 day ago
- US Market Wrap: Stocks hit as AI growth concerns weigh on sentiment 1 day ago
- Newsquawk Daily European Equity Opening News - 16th October 20261 day ago
- Weekly US Earnings Estimates: 19th-23rd October 2026: Earnings pick up with META, TSLA, SPCX, LRCX, and NFLX the highlights1 day ago
- Daily US Equity Opening News: 16th October 2026: TSLA gains on Roadster reveal; NFLX slips as Content Chief to leave; TRV earnings underwhelm1 day ago
- Nvidia (NVDA) expands tools for building AI-powered games with Unreal Engine 51 day ago
- US FAA is set to approve certification for the Boeing (BA) 737 MAX 10, sources report; potentially as soon as in the next week1 day ago
- Daily US Earnings Estimates: 19th October 2026: FITB, WRB, and STLD1 day ago
- US officials pressed Beijing on market access issues for Mastercard (MA) and Citigroup (C) during at least two bilateral meetings with Chinese counterparts in Bangkok this week, CNBC reports, citing a source1 day ago
- Apple (AAPL) set for UK legal fight over iPhone tap-to-pay rules, FT reports1 day ago
- US EQUITY OPEN: Stocks mixed at the open as AI stock rout continues1 day ago
- US DoJ officials have reportedly signalled their preference to settle antitrust lawsuit against Apple (AAPL), The Information reports citing sources1 day ago
- US PREMARKET MOVERS: TSLA, NFLX, VRNS, AA, TRV, MSTR, WDAY, ECHO1 day ago
- Charles Schwab (SCHW) CEO says seeing record levels of interest in fixed income; Brokerage is blocking unauthorised AI agents1 day ago
- Apple (AAPL) iPhone duo delivery date slips to January 25th1 day ago
- Apple's (AAPL) iPhone Duo sells out minutes after pre-orders open, according to Apple Insider1 day ago
- ExxonMobil (XOM) says changes in margins to impact Q3 chemical products earnings by USD -0.6bln Q/Q1 day ago
- Nvidia's (NVDA) RTX Spark laptops have launched globally, starting at USD 2,5991 day ago
- Travelers (TRV) Q3 2026 (USD): Adj. EPS 9.18 (exp. 7.39), Revenue 12.4bln (exp. 11.4bln); Net Premiums Written 11.48bln (exp. 11.40bln), Catastrophe Loss 538mln (exp. 695mln)1 day ago
- Truist Financial (TFC) Q3 2026 (USD): EPS 1.16 (exp. 1.14), Revenue 3.79bln (exp. 5.35bln)1 day ago
The feed had this first.
Use the Platform